What is emphysema? Learn about the symptoms, causes, and how this chronic lung disease can restrict daily activities. Discover the impact of emphysema and find ways to manage this condition.

Understanding Emphysema: The Debilitating Lung Disease

Emphysema is a chronic and progressive lung disease that is part of the broader group of conditions known as chronic obstructive pulmonary disease (COPD). In emphysema, the air sacs in the lungs (alveoli) become damaged and enlarged, making it increasingly difficult for the lungs to function properly. This impairs the ability to breathe, leading to a range of symptoms that can significantly impact an individual’s quality of life.

Symptoms of Emphysema: Struggling to Breathe

The primary symptom of emphysema is shortness of breath, which often worsens over time as the disease progresses. Patients may experience difficulty breathing during physical activity, and in severe cases, even simple tasks such as getting dressed or walking can become a challenge. Other common symptoms of emphysema include:

• Chronic cough, sometimes with mucus production
• Wheezing or whistling sound when breathing
• Chest tightness or discomfort
• Fatigue and lack of energy
• Frequent respiratory infections

Causes of Emphysema: Understanding the Risk Factors

The primary cause of emphysema is long-term exposure to irritants that damage the lungs, with cigarette smoking being the most common culprit. Other risk factors for developing emphysema include:

1. Secondhand smoke exposure
2. Air pollution, such as from industrial or household sources
3. Genetic factors, particularly a deficiency in the protein alpha-1 antitrypsin
4. Occupational exposure to dust, chemicals, or fumes

Impact of Emphysema on Daily Life: Adapting to Breathing Challenges

Emphysema can have a significant impact on an individual’s daily life, as the disease can make even basic activities challenging. Patients may experience difficulty with:

• Performing everyday tasks, such as cleaning, cooking, or bathing
• Engaging in physical activity, including exercise or recreational hobbies
• Maintaining social connections and participating in social activities
• Sleeping comfortably due to breathing difficulties

Managing Emphysema: Strategies for Improving Quality of Life

While there is no cure for emphysema, there are various treatments and lifestyle modifications that can help manage the symptoms and slow the progression of the disease. These include:

1. Medication, such as bronchodilators and corticosteroids, to help open the airways and reduce inflammation
2. Oxygen therapy, which can improve oxygen levels in the blood and make breathing easier
3. Pulmonary rehabilitation programs, which combine exercise, education, and support to help patients better manage their condition
4. Quitting smoking and avoiding secondhand smoke exposure
5. Maintaining a healthy diet and staying physically active to the extent possible

The Importance of Early Diagnosis and Treatment

Early diagnosis and treatment of emphysema are crucial for slowing the progression of the disease and improving the patient’s quality of life. Regular check-ups with a healthcare provider, including lung function tests, can help identify emphysema in its early stages, allowing for timely interventions and the implementation of effective management strategies.

Adapting to Life with Emphysema: Coping Strategies

Living with emphysema can be challenging, but there are various coping strategies that can help patients and their loved ones navigate the disease. These include:

• Joining support groups to connect with others facing similar challenges
• Practicing stress management techniques, such as meditation or deep breathing exercises
• Seeking emotional support from mental health professionals or counselors
• Advocating for accessibility and accommodations in the workplace or at home

Emphysema is a complex and debilitating lung disease that can have a significant impact on an individual’s daily life. By understanding the symptoms, causes, and available management strategies, individuals with emphysema can work closely with their healthcare providers to develop a comprehensive plan to improve their quality of life and adapt to the challenges posed by this chronic condition.

Emphysema Puts Restrictions on Daily Life

• Zephyr hospitals

• Contact us

• Download centre

We use cookies on our website Some of them are essential, while some help us to improve this website and your experience.

• Essential

• Statistics

• Marketing

• External Media

Accept all

Save preferences

Individual cookie settings

Cookie-Details

Data privacy statement

Imprint

Cookie preferences

We use cookies on our website Some of them are essential, while some help us to improve this website and your experience.

Accept all

Save preferences

Essential (1)

Essential cookies enable basic functions and are necessary for the website to function properly.

Show cookie information

Hide cookie information

Name	Borlabs Cookie
Provider	Owner of this website
Purpose	Saves the settings of the visitors selected in the Cookie Box of Borlabs Cookie.
Cookie Name	borlabs-cookie
Cookie expiration	1 year

Statistics (4)

Statistics cookies collect information. This information helps us to understand how our visitors use our website.

Show cookie information

Hide cookie information

Accept
Name	Google Analytics
Provider	Google LLC
Purpose	Cookie from Google for website analyses. Creates statistical data about how the visitor uses the website.
Privacy Policy	https://policies.google.com/privacy
Cookie Name	_ga,_gat,_gid
Cookie expiration	2 years

Accept
Name	Google Tag Manager
Provider	Google LLC
Purpose	Cookie from Google to control the expanded script and event handling.
Privacy Policy	https://policies.google.com/privacy
Cookie Name	_ga,_gat,_gid
Cookie expiration	2 years

Accept
Name	Keap
Provider	Keap
Purpose	With Keap statistics cookies, the number of visitor appearances and visitor flows on our website can be measured and analysed. This information helps us to perform necessary improvements on our website and to increase performance.
Privacy Policy	https://keap.com/legal/privacy-policy
Cookie expiration	2 Years

Accept
Name	Hotjar
Provider	Hotjar Ltd.
Purpose	Hotjar is an analysis tools for the user activity of Hotjar Ltd. We use Hotjar to understand how users interact with our website.
Privacy Policy	https://www.hotjar.com/legal/policies/privacy/
Host(s)	*.hotjar.com
Cookie Name	_hjClosedSurveyInvites, _hjDonePolls, _hjMinimizedPolls, _hjDoneTestersWidgets, _hjIncludedInSample, _hjShownFeedbackMessage, _hjid, _hjRecordingLastActivity, hjTLDTest, _hjUserAttributesHash, _hjCachedUserAttributes, _hjLocalStorageTest, _hjptid
Cookie expiration	Session / 1 year

Marketing (2)

Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Show cookie information

Hide cookie information

Accept
Name	Google Marketing Services
Provider	Google LLC
Purpose	Display advertisements on other websites in a more targeted manner to only present users with ads that potentially match their interests.
Cookie expiration	1 year

Accept
Name	Google Ads
Provider	Google LLC
Purpose	Display advertisements on other websites in a more targeted manner to only present users with ads that potentially match their interests.
Cookie Name	1 year

External Media (4)

Content from video platforms and social media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Show cookie information

Hide cookie information

Accept
Name	Facebook
Provider	Facebook
Purpose	Is used to unlock Facebook content.
Privacy Policy	https://www.facebook.com/privacy/explanation
Host(s)	.facebook.com

Accept
Name	Facebook Pixel
Provider	Facebook Ireland Limited
Purpose	Cookie from Facebook that is used for website analysis, ad targeting and advertising measurement.
Privacy Policy	https://www.facebook.com/policies/cookies
Cookie Name	_fbp,act,c_user,datr,fr,m_pixel_ration,pl,presence,sb,spin,wd,xs
Cookie expiration	Session / 1 year

Accept
Name	Google Maps
Provider	Google
Purpose	Used to unlock Google Maps contents.
Privacy Policy	https://policies.google.com/privacy
Host(s)	.google.com
Cookie Name	NID
Cookie expiration	6 months

Accept
Name	YouTube
Provider	YouTube
Purpose	Is used to unlock YouTube content.
Privacy Policy	https://policies.google.com/privacy
Host(s)	google.com
Cookie Name	NID
Cookie expiration	6 months

Data privacy statement

Imprint

COPD Heterogeneity and Progression: Emphysema-Predominant and Non-Emphysema-Predominant Disease | American Journal of Epidemiology

Journal Article
Accepted manuscript

Get access

Peter J Castaldi,

Peter J Castaldi

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

Zhonghui Xu,

Zhonghui Xu

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

Kendra A Young,

Kendra A Young

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

John E Hokanson,

John E Hokanson

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

David A Lynch,

David A Lynch

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

Stephen M Humphries,

Stephen M Humphries

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

James C Ross,

James C Ross

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

Michael H Cho,

Michael H Cho

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

Craig P Hersh,

Craig P Hersh

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

James D Crapo,

James D Crapo

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

. .. Show more

Matthew Strand,

Matthew Strand

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

Edwin K Silverman

Edwin K Silverman

Search for other works by this author on:

Oxford Academic

PubMed

Google Scholar

American Journal of Epidemiology, kwad114, https://doi.org/10.1093/aje/kwad114

Published:

09 May 2023

Article history

Received:

17 March 2022

Revision received:

20 December 2022

Accepted:

04 May 2023

Published:

09 May 2023

Navbar Search Filter

American Journal of EpidemiologyPublic Health and EpidemiologyBooksJournalsOxford Academic
Mobile Enter search term

Close

Navbar Search Filter

American Journal of EpidemiologyPublic Health and EpidemiologyBooksJournalsOxford Academic
Enter search term

Advanced Search

Abstract

While variation in emphysema between COPD patients is well-recognized, clinically applicable definitions of emphysema-predominant (EPD) and non-emphysema-predominant (NEPD) subtypes have not been established. To study the clinical relevance of EPD and NEPD subtypes, we tested the association of these subtypes to prospective FEV1 decline and mortality in 3,427 subjects with GOLD spirometric grade 2-4 COPD at baseline in the COPDGene Study, an ongoing national multicenter study that started in 2007. NEPD was defined as airflow obstruction with <5% computed tomography (CT) quantitative densitometric emphysema at -950 Hounsfield units, and EPD was defined as airflow obstruction with >=10% CT emphysema. Mixed effects models for FEV1 demonstrated larger average annual FEV1 loss in EPD versus NEPD subjects (-10.2 ml/yr, p<0.001), and subtype-specific associations to FEV1 decline were identified. Cox proportional hazards models showed higher risk of mortality in EPD versus NEPD (HR 1.46, p<0.001). To determine whether the NEPD and EPD dichotomy is captured by previously described COPDGene subtypes, we used logistic regression and receiver-operator characteristic analysis to predict NEPD/EPD membership using these previous subtype definitions, which generally showed excellent discrimination with AUCs > 0. 9. NEPD and EPD COPD subtypes capture important aspects of COPD heterogeneity and are associated with different rates of disease progression and mortality.

COPD, Emphysema, COPD subtypes

Accepted manuscripts

Accepted manuscripts are PDF versions of the author’s final manuscript, as accepted for publication by the journal but prior to copyediting or typesetting. They can be cited using the author(s), article title, journal title, year of online publication, and DOI. They will be replaced by the final typeset articles, which may therefore contain changes. The DOI will remain the same throughout.

This content is only available as a PDF.

© The Author(s) 2023. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: [email protected]

Issue Section:

ORIGINAL CONTRIBUTION

You do not currently have access to this article.

Download all slides

Sign in

Get help with access

Get help with access

Institutional access

Access to content on Oxford Academic is often provided through institutional subscriptions and purchases. If you are a member of an institution with an active account, you may be able to access content in one of the following ways:

IP based access

Typically, access is provided across an institutional network to a range of IP addresses. This authentication occurs automatically, and it is not possible to sign out of an IP authenticated account.

Sign in through your institution

Choose this option to get remote access when outside your institution. Shibboleth / Open Athens technology is used to provide single sign-on between your institution’s website and Oxford Academic.

1. Click Sign in through your institution.
2. Select your institution from the list provided, which will take you to your institution’s website to sign in.
3. When on the institution site, please use the credentials provided by your institution. Do not use an Oxford Academic personal account.
4. Following successful sign in, you will be returned to Oxford Academic.

If your institution is not listed or you cannot sign in to your institution’s website, please contact your librarian or administrator.

Sign in with a library card

Enter your library card number to sign in. If you cannot sign in, please contact your librarian.

Society Members

Society member access to a journal is achieved in one of the following ways:

Sign in through society site

Many societies offer single sign-on between the society website and Oxford Academic. If you see ‘Sign in through society site’ in the sign in pane within a journal:

1. Click Sign in through society site.
2. When on the society site, please use the credentials provided by that society. Do not use an Oxford Academic personal account.
3. Following successful sign in, you will be returned to Oxford Academic.

If you do not have a society account or have forgotten your username or password, please contact your society.

Sign in using a personal account

Some societies use Oxford Academic personal accounts to provide access to their members. See below.

Personal account

A personal account can be used to get email alerts, save searches, purchase content, and activate subscriptions.

Some societies use Oxford Academic personal accounts to provide access to their members.

Viewing your signed in accounts

Click the account icon in the top right to:

• View your signed in personal account and access account management features.
• View the institutional accounts that are providing access.

Signed in but can’t access content

Oxford Academic is home to a wide variety of products. The institutional subscription may not cover the content that you are trying to access. If you believe you should have access to that content, please contact your librarian.

Institutional account management

For librarians and administrators, your personal account also provides access to institutional account management. Here you will find options to view and activate subscriptions, manage institutional settings and access options, access usage statistics, and more.

Purchase

Subscription prices and ordering for this journal

Purchasing options for books and journals across Oxford Academic

Short-term Access

To purchase short-term access, please sign in to your personal account above.

Don’t already have a personal account? Register

COPD Heterogeneity and Progression: Emphysema-Predominant and Non-Emphysema-Predominant Disease – 24 Hours access

EUR €36.00

GBP £32.00

USD $39.00

Advertisement

Citations

Altmetric

More metrics information

Email alerts

Article activity alert

Advance article alerts

New issue alert

Receive exclusive offers and updates from Oxford Academic

Citing articles via

• 
  

  
  Latest
  

• 
  

  
  Most Read
  

• 
  

  
  Most Cited
  

Response to Boniface et al.